Literature DB >> 12663624

Performance of serum cystatin-C versus serum creatinine in subjects with type 1 diabetes.

Martin Buysschaert, Ihab Joudi, Pierre Wallemacq, Michel P Hermans.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12663624     DOI： 10.2337/diacare.26.4.1320

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  6 in total

1.  The potential of Cystatin C and small dense LDL as biomarkers of coronary artery disease risk in a young Indian population.

Authors:  Anjali Manocha; Flora Gupta; Rajneesh Jain; Seema Bhargava; Mamta Kankra; Sabari Das; L M Srivastava
Journal:  Mol Cell Biochem       Date:  2013-12-20       Impact factor: 3.396

2.  Systematic shifts in cystatin C between 2006 and 2010.

Authors:  David M Maahs; Diana Jalal; Kim McFann; Marian Rewers; Janet K Snell-Bergeon
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 8.237

3.  Relationship between cystatin C and coronary artery atherosclerosis progression differs by type 1 diabetes.

Authors:  David M Maahs; Janet K Snell-Bergeon; John E Hokanson; Gregory L Kinney; Tomas Berl; Marian Rewers; Lorraine G Ogden
Journal:  Diabetes Technol Ther       Date:  2010-01       Impact factor: 6.118

4.  Cystatin C--a paradigm of evidence based laboratory medicine.

Authors:  Janice S C Chew; Mohammed Saleem; Christopher M Florkowski; Peter M George
Journal:  Clin Biochem Rev       Date:  2008-05

5.  Cystatin C- and Creatinine-Based Estimates of Glomerular Filtration Rate in Dapagliflozin Phase 3 Clinical Trials.

Authors:  Christian Mende; Arie Katz
Journal:  Diabetes Ther       Date:  2016-02-22       Impact factor: 2.945

6.  Cystatin C, Vitamin D and Thyroid Function Test Profile in Chronic Kidney Disease Patients.

Authors:  Marlene Tapper; Donovan A McGrowder; Lowell Dilworth; Adedamola Soyibo
Journal:  Diseases       Date:  2021-01-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.